-
-
-
-
-
-
-
UK regulator expands Imcivree approval to hypothalamic obesity
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $151 at Canaccord
-
-
-
-
-
-
-
Rhythm Pharmaceuticals gets EU approval for obesity drug IMCIVREE
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Lowered to $100 at H.C. Wainwright
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Lowered to $140 at Canaccord
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $125 at H.C. Wainwright
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $157 at Goldman Sachs
-
479,030 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


